Humana — 2025 Investments
3 investments dated 2025 · listed companies and verified rows first · show all
Post Acute Analytics provides data analytics and clinical decision support software for healthcare providers and payers to improve patient outcomes and reduce total cost of care across the continuum of post-acute and acute settings.
AI & Machine LearningData & InfrastructureHealthtechIrving, US
Saqib Akhter(Chief Executive Officer & Co-Founder)John F. Taylor(Executive Officer, Director)
BoardMichael Landerer(Director)Taylor Whitman(Director)Russell Hirsch(Director)Arnold Whitman(Director)
Co-investorsEquitage Ventures, L.L.C.Generator VenturesWarburg Pincus
Thyme has partnered with Altruist to create Hazel, an AI product for wealth management professionals.
AI & Machine LearningEnterprise SoftwareFintechSan Francisco, US
Daniel Lantz(Founder)inFernando San Martin(Founder)in
Co-investorsY CombinatorAlleyCorpConcord Health PartnersCVS Health VenturesForesite CapitalFrist Cressey Ventures+1 more
Thyme Care develops software to enhance care coordination and outcomes for cancer patients.
Digital HealthHealthtechNashville, US
Robert Green(Executive Officer, Director)Robin Shah(Executive Officer, Director)in
BoardBrian Belsky(Director)inElizabeth Canis(Director)inBrenton Fargnoli(Director)inVineeta Agarwala(Director)in
Co-investorsAlleyCorpAndreessen HorowitzCorewell Health VenturesCVS Health VenturesEcho Health VenturesForesite Capital+4 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.